Therefore, we hypothesize that CPS1 and citrin promoters could function in the glioblastoma, glioblastoma multiforme, stomach adenocarcinoma, and stomach and esophagus carcinoma cells. This evidence concerns the gene SLC25A13 and glioblastoma.